"DaVita Kidney Care is a division of DaVita Inc., a Fortune 500 company, providing a variety of health care services to patients suffering with kidney disease throughout the United States and abroad. Our dialysis centers provide hemodialysis and peritoneal dialysis to help treat patients with chronic kidney failure and end stage renal disease. We strive to improve patients' quality of life by innovating clinical care, and by offering integrated treatment plans, home dialysis, personalized care teams and convenient health-management services."

During the past decade, DaVita K Street conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "DaVita K Street" are "End Stage Renal Disease" (2 trials), "ESRD" (1 trials), "Gut Microbiome Dysbiosis" (1 trials) and "Hyperkalemia" (1 trials). Many other conditions were trialed in "DaVita K Street" in a lesser frequency.

Most popular intervention types in "DaVita K Street" are "Dietary Supplement" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "P-inulin" (1 trials) and "Patiromer" (1 trials). Other intervention names were less common.

The vast majority of trials in "DaVita K Street" are 2 trials for "All" genders.

Currently, there are NaN active trials in "DaVita K Street". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in DaVita K Street, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in DaVita K Street, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".